DarioHealth is the latest to bring its mobile-friendly glucose management system to store shelves, with the company announcing today that it will be bringing its so-called “Membership-in-a-Box” to physical retail chains like Best Buy.
The offering, already available through Best Buy’s online storefront, consists of the company’s connected blood glucose meter, 25 test strips, 10 lancets, 10 covers...
Welldoc is tapping Astellas Pharma to assist Japanese and Asian commercialization efforts for the former’s digital therapeutic for patients with diabetes, the companies announced yesterday.
To kick off the deal, Astellas is making an upfront $15 million payment to Welldoc, which will allow the pharma to jointly develop and commercialize the BlueStar product in the region. The two will also be...
Livongo is touting new data regarding the efficacy of its device-and-coaching disease management platform, this time among those using its Livongo for Hypertension and Livongo for Diabetes products together.
The results, which are set to be formally presented this weekend at the American Heart Association Scientific Sessions 2019, identified significant decreases in hypertensive blood pressure as...
Type 1 diabetes management and CGM integration are now on the table for WellDoc’s BlueStar, a management platform well known for being the first mobile health product to secure reimbursement as a diabetes therapy.
Thanks to a new FDA clearance, the company’s seventh, BlueStar will include integrated glucose level insights related to food, medication and activity that are based on the data from...
Life insurer John Hancock has unveiled a new wearable program dubbed Aspire aimed at helping its members with diabetes manage the condition. The program was born out of a partnership with Verily and digital diabetes care platform Onduo.
Users of the new platform can access diabetes coaching via Onduo’s virtual clinic. The program also has fiscal rewards. According to the company, members using...
Fitbit and Taiwan-based diabetes management app Health2Sync announced last week that Fitbit health, sleep and fitness data can now be integrated with the Health2Sync app to support Health2Sync’s 360,000 users in Taiwan and Japan to better manage their diabetes.
The voluntary integration of Fitbit data with the Health2Sync platform gives users who have a Fitbit account access to an in-app...
Hello Heart, maker of a digital chronic disease health program for employees, has raised $12 million in Series B funding. The round was led by Khosla Ventures, with additional support from previous backers BlueRun Ventures, Maven Ventures and Resolute Ventures.
WHAT THEY DO
Hello Heart’s bread and butter is its app-driven platform for hypertension, blood pressure and general cardiovascular health...
Following a major sales bump in the second quarter of 2019, Abbott Laboratories is planning to significantly ramp up manufacturing for its FreeStyle Libre continuous glucose monitoring system, the company shared during an investor’s call this morning.
Specifically, the company highlighted a 72.9% increase in organic sales growth during the three-month period, reaching a worldwide total sales...
Gone are the days of endless finger pricks to test blood glucose levels and complicated mental calculations to deduce carbohydrate ratios with insulin. The growth of people with diabetes by 314 million in the last 34 years has created an ever-expanding market in diabetes management products.
Consumers are now inundated with new technology streamlining lives with less needles and more real-time...
One Drop’s wireless blood glucose monitor is now being sold in certain US Apple Stores, according to a release from the company.
One Drop’s platform, which is integrated with Apple’s Health Records, allows iPhone users to more conveniently check their glucose levels and share that data, alongside the rest of their personal health record, with providers. Additionally, purchase of the system at an...
